BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12957251)

  • 21. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer.
    Yan MH; Liu F; Qu BL; Cai BN; Yu W; Dai XK
    World J Gastrointest Oncol; 2021 Nov; 13(11):1781-1790. PubMed ID: 34853650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
    Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
    Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.
    Alshawa A; Cadena AP; Stephen B; Reddy A; Mendoza TR; McQuinn L; Lawhorn K; Zarifa A; Bernhardt AM; Fessaheye S; Warneke CL; Chang JY; Naing A
    Invest New Drugs; 2021 Aug; 39(4):1113-1122. PubMed ID: 33580845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
    Small W; James JL; Moore TD; Fintel DJ; Lutz ST; Movsas B; Suntharalingam M; Garces YI; Ivker R; Moulder J; Pugh S; Berk LB
    Am J Clin Oncol; 2018 Apr; 41(4):396-401. PubMed ID: 27100959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifostine reduces radiation-induced complications in a murine model of expander-based breast reconstruction.
    Felice PA; Nelson NS; Page EE; Deshpande SS; Donneys A; Rodriguez J; Buchman SR
    Plast Reconstr Surg; 2014 Oct; 134(4):551e-560e. PubMed ID: 25357049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
    Wang Z; Chen M; Sun J; Jiang S; Wang L; Wang X; Sahoo N; Gunn GB; Frank SJ; Nguyen QN; Liao Z; Chang JY; Zhu XR; Zhang X
    Radiother Oncol; 2020 May; 146():200-204. PubMed ID: 32220701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.
    Wurstbauer K; Kazil M; Meinschad M; Pinter R; De Vries C; Clemens P; Kreuter C; Hernler T; Hitzl W; Cerkl P; Künzler T; De Vries A
    Radiat Oncol; 2022 Jul; 17(1):120. PubMed ID: 35799182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
    van der Weijst L; Azria D; Berkovic P; Boisselier P; Briers E; Bultijnck R; Chang-Claude J; Choudhury A; Defraene G; Demontois S; Elliott RM; Ennis D; Faivre-Finn C; Franceschini M; Giandini T; Giraldo A; Gutiérrez-Enríquez S; Herskind C; Higginson DS; Kerns SL; Johnson K; Lambrecht M; Lang P; Ramos M; Rancati T; Rimner A; Rosenstein BS; De Ruysscher D; Salem A; Sangalli C; Seibold P; Sosa Fajardo P; Sperk E; Stobart H; Summersgill H; Surmont V; Symonds P; Taboada-Valladares B; Talbot CJ; Vega A; Veldeman L; Veldwijk MR; Ward T; Webb A; West CML; Lievens Y;
    Radiother Oncol; 2022 Nov; 176():127-137. PubMed ID: 36195214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
    Van der Weijst L; Aguado-Barrera ME; Azria D; Berkovic P; Boisselier P; Briers E; Bultijnck R; Calvo-Crespo P; Chang-Claude J; Choudhury A; Defraene G; Demontois S; Dunning AM; Elliott RM; Ennis D; Faivre-Finn C; Franceschini M; Gutiérrez-Enríquez S; Herskind C; Higginson DS; Kerns SL; Johnson K; Mollà M; Lambrecht M; Ramos M; Rancati T; Rimner A; Rosenstein BS; De Ruysscher D; Salem A; Sangalli C; Seibold P; Sosa-Fajardo P; Sperk E; Stobart H; Summersgill H; Surmont V; Symonds P; Taboada-Lorenzo B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Veldwijk MR; Ward T; Webb A; West CML; ; Lievens Y
    Lung Cancer; 2022 Apr; 166():228-241. PubMed ID: 35334417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral glutamine supplementation reduces radiotherapy- induced esophagitis in lung cancer patients.
    Gul K; Muge A; Taner A; Sehri E
    Asian Pac J Cancer Prev; 2015; 16(1):53-8. PubMed ID: 25640390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Ishikawa H; Ogawa K; Tsuji H
    Jpn J Radiol; 2021 Jul; 39(7):703-709. PubMed ID: 33608792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial.
    Valdes G; Scholey J; Nano TF; Gennatas ED; Mohindra P; Mohammed N; Zeng J; Kotecha R; Rosen LR; Chang J; Tsai HK; Urbanic JJ; Vargas CE; Yu NY; Ungar LH; Eaton E; Simone CB
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):66-77. PubMed ID: 38000701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
    Multhoff G; Seier S; Stangl S; Sievert W; Shevtsov M; Werner C; Pockley AG; Blankenstein C; Hildebrandt M; Offner R; Ahrens N; Kokowski K; Hautmann M; Rödel C; Fietkau R; Lubgan D; Huber R; Hautmann H; Duell T; Molls M; Specht H; Haller B; Devecka M; Sauter A; Combs SE
    Clin Cancer Res; 2020 Oct; 26(20):5368-5379. PubMed ID: 32873573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapy.
    Zhao Z; Liao H; Ju Y
    J Tradit Chin Med; 2016 Feb; 36(1):14-8. PubMed ID: 26946613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer.
    Delgado BD; Enguix-Riego MV; Fernández de Bobadilla JC; Herrero Rivera D; Nieto-Guerrero Gómez JM; Praena-Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; Fernandez Fernandez MDC; Lopez Guerra JL
    Radiother Oncol; 2019 Jun; 135():161-169. PubMed ID: 31015163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.
    Fogh SE; Deshmukh S; Berk LB; Dueck AC; Roof K; Yacoub S; Gergel T; Stephans K; Rimner A; DeNittis A; Pablo J; Rineer J; Williams TM; Bruner D
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):786-796. PubMed ID: 28244415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decision analytic modeling for the economic analysis of proton radiotherapy for non-small cell lung cancer.
    Smith WP; Richard PJ; Zeng J; Apisarnthanarax S; Rengan R; Phillips MH
    Transl Lung Cancer Res; 2018 Apr; 7(2):122-133. PubMed ID: 29876311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.
    Verma V; Simone CB; Werner-Wasik M
    Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28885561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617.
    Ladbury C; Li R; Danesharasteh A; Ertem Z; Tam A; Liu J; Hao C; Li R; McGee H; Sampath S; Williams T; Glaser S; Khasawneh M; Liao Z; Lee P; Ryckman J; Shaikh P; Amini A
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1287-1296. PubMed ID: 37406826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer.
    Mix M; Ramnath N; Gomez J; de Groot C; Rajan S; Dibaj S; Tan W; Rustum Y; Jameson MB; Singh AK
    World J Clin Oncol; 2015 Oct; 6(5):156-65. PubMed ID: 26468452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.